Common name
3,6-dimethylimidazo[1,2-a]pyridine
IUPAC name
3,6-dimethylimidazo[1,2-a]pyridine
SMILES
Cc1n2c(nc1)ccc(c2)C
Common name
3,6-dimethylimidazo[1,2-a]pyridine
IUPAC name
3,6-dimethylimidazo[1,2-a]pyridine
SMILES
Cc1n2c(nc1)ccc(c2)C
INCHI
InChI=1S/C9H10N2/c1-7-3-4-9-10-5-8(2)11(9)6-7/h3-6H,1-2H3
FORMULA
C9H10N2
Common name
3,6-dimethylimidazo[1,2-a]pyridine
IUPAC name
3,6-dimethylimidazo[1,2-a]pyridine
Molecular weight
149.213
clogP
-0.016
clogS
-1.876
Frequency
0.0003
HBond Acceptor
0
HBond Donor
1
Total PolarSurface Area
15.91
Number of Rings
2
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00302 | Zolpidem |
|
Hypnotics and Sedatives; GABA-A Receptor Agonists; Nervous System; Psycholeptics; Benzodiazepine Related Drugs; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; | For the short-term treatment of insomnia. |
1 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4awo_ligand_2_27.mol2 | 4awo | 0.54955 | -8.83 | n1c(ccc(c1)C=O)N1[C@H]2CCC[C@@H]1CC2 | 16 |
| 4ddl_ligand_1_3.mol2 | 4ddl | 0.548077 | -6.59 | c1cc(c(nc1)N1CCC(CC1)C(O)(C)C)C | 17 |
| 5ap1_ligand_2_20.mol2 | 5ap1 | 0.542056 | -7.72 | C1(CCCCC1)Nc1ncccc1C#N | 15 |
| 5ap4_ligand_2_20.mol2 | 5ap4 | 0.542056 | -7.70 | N(C1CCCCC1)c1ncccc1C#N | 15 |
| 4bdi_ligand.mol2 | 4bdi | 0.535088 | -7.72 | C(=O)(C)N1CCC(CC1)C(=O)Nc1ncc(cc1)C | 20 |
| 4awq_ligand_2_15.mol2 | 4awq | 0.516949 | -9.04 | C1C[C@H]2CC[C@@H](C1)N2c1ccc(C(=O)N)cn1 | 17 |
| 4awp_ligand_2_15.mol2 | 4awp | 0.516949 | -9.00 | C1C[C@@H]2CC[C@H](C1)N2c1ccc(cn1)C(=O)N | 17 |
| 4hvs_ligand_3_10.mol2 | 4hvs | 0.511364 | -6.83 | CNc1ncc(C)cc1 | 9 |
100 ,
11
